- Poster presentation
- Open Access
Clinical and histological presentations of experimental autoimmune myocarditis in rats using different immunization schemes
© Jeuthe et al.; licensee BioMed Central Ltd. 2014
- Published: 16 January 2014
- Cardiac Magnetic Resonance
- Inflammatory Infiltrate
- Cardiac Magnetic Resonance Imaging
- Immunization Scheme
Myocarditis is an inflammatory cardiac disease with a wide range of symptoms and various etiologies. The diagnostic workup and the treatment of myocarditis remain highly controversial. Therefore, there is a high demand for reliable animal models. Experimental autoimmune myocarditis (EAM) represents a model of human myocarditis and heart failure. In this study we investigated the histological, functional and clinical presentations of EAM induced by different immunization schemes.
Male young Lewis rats were divided into 5 groups immunized by porcine myocardial myosin: 1 mg subcutaneously (SC) on day 0 and 7; 0.25 mg subcutaneously into rear footpads (RF) on day 0; 0.5 mg RF on day 0; and 1 mg RF on day 0; and a sham group, injected with a vehicle solution without myosin into the RF on day 0. Rats were sacrificed on day 21 after assessment of left ventricular (LV) function by cardiac magnetic resonance imaging and cardiac catheterization under isoflurane anesthesia. The ventricle weight was measured and the location, type and degree of myocardial inflammatory infiltrates were determined by conventional histology and immunohistochemistry (CD 68).
Rats immunized in the RF showed a mortality of 20%, 20% and 44% for the 0.25 mg, 0.5 mg and 1 mg myosin doses respectively, while the SC group and the RF sham group yielded a mortality of 0%. Morbidity as defined by inflammatory infiltrates on HE staining was 22% in the SC immunized rats, 0% in the RF sham group and 100% in all actively RF immunized groups. Histologically we observed macrophage-rich inflammatory infiltrates in both ventricles. All RF groups immunized with myosin showed augmented relative ventricle weight and spleen weight, increased LV end-diastolic pressure, reduced LV developed pressure and reduced LV ejection fraction, without any dose-dependend effect.
Subcutaneous immunization into the neck and flanks failed to induce a reproducible EAM, while RF administration of myosin reliably led to EAM. Low-dose RF myosin application induces the complete histological and clinical picture of EAM, associated with lower mortality, non-specific symptoms and animal distress.
Sarah Jeuthe, this work is supported by a research grant of the German Cardiac Society (DGK).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.